Cite
HARVARD Citation
Yang, M. et al. (2022). An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy. Biomaterials science. pp. 7077-7092. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yang, M. et al. (2022). An injectable vitreous substitute with sustained release of metformin for enhanced uveal melanoma immunotherapy. Biomaterials science. pp. 7077-7092. [Online].